Study of Isomyosamine for muscle loss after hip or thigh fracture
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study tests an investigational drug called Isomyosamine, which aims to reduce inflammation and prevent muscle loss after a hip or thigh fracture. It is designed for older adults who are at risk for frailty or sarcopenia after their injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 60 and 85 years old
- Have a broken hip or thigh bone from a fall
- Have frailty, muscle loss, or high inflammation markers in the blood
- Weigh at least 77 pounds (35 kg)
- Not be taking certain medications like anti-TNF drugs or diabetes medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug that may help older people who break a hip and have low muscle mass (sarcopenia). It aims to see if the drug can help preserve muscle strength and speed up recovery after surgery.
This study looks at how muscle loss (sarcopenia) affects recovery after a hip fracture, comparing people of normal weight and those with obesity. It may help find better ways to support recovery.
This trial looks at how muscle health affects your ability to get back to normal activities after hip replacement surgery for a broken hip or severe arthritis. By using MRI scans and other tests, researchers hope to understand if having less muscle makes recovery harder.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This study looks at frailty in older adults who have a certain type of hip fracture. It may help doctors better understand how frailty affects recovery after hip surgery.
This study looks at how frailty and inflammation affect recovery after a hip fracture in older adults. It aims to find biomarkers that could help personalize care.
Hear when a new Sarcopenia in Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.